INCREDIBLE: IA reveals NEW and REVOLUTIONARY ANTIBIOTICS, a HISTORICAL DISCOVERY after 60 years!

New breakthrough thanks to AI: An antibiotic revolution

Artificial intelligence (AI) is revolutionizing a number of fields, including healthcare. This is confirmed by the discovery of a new class of antibiotics, made possible by this technology after more than fifty years without any major innovation in this field.

A giant step forward against resistant bacteria

Advanced artificial intelligence models have identified a new agent capable of combating multi-resistant Staphylococcus aureus (MRSA), a bacterial strain responsible for thousands of deaths worldwide every year. This breakthrough could prove decisive in the fight against growing resistance to existing antibiotics.

Prediction of high-performance molecules

James Collins from MIT, co-author of the study, explains that the aim was to evaluate the potential efficacy of certain molecules as antibiotics using AI models. This experimental approach offers a more cost-effective and efficient method of examining the chemical structure of compounds in a novel way.

Promising results published in "Nature" magazine

The findings of this research are now available in the scientific journal "Nature". The article summarizes the work of 21 researchers who contributed to the study.

Towards a better understanding of AI models

MIT scientists set out to understand how artificial neural networks used by AI to learn and generate innovative ideas work. Their approach was based on a deep learning model capable of predicting antibacterial efficacy and non-toxicity in humans.

Compound selection method

The MIT team used a compound selection method based on an initial screening of almost 39,000 substances for their action against MRSA, followed by a detailed analysis of their chemical structure. MIT researcher Felix Wong stresses the importance of demystifying the internal processes of these models.

Finding a new antimicrobial compound

To refine the selection, several artificial intelligence models were used to assess the toxicity of the molecules in relation to three different human cell types.

AI algorithms analyzed nearly 12 million over-the-counter compounds, identifying five promising molecule families against MRSA. After acquiring and testing nearly 280 of these compounds, two promising candidates were identified.

Positive tests on animal models

Experiments carried out on mice, simulating either cutaneous or systemic MRSA infection, demonstrated the efficacy of the two agents identified, reducing the quantity of bacteria in the treated organisms by a factor of ten.

In conclusion, thanks to the application of artificial intelligence in the pharmaceutical field, a new era could open up for the research and development of antibiotics capable of countering the escape strategies of resistant bacteria.